Is the Similac Lawsuit Real in 2026?
Quick Answer
- The Similac lawsuit is real: Abbott agreed to pay $670 million to settle about 2,000 NEC cases in August 2026.
- Per-person payout amounts from that settlement have not been made public; older jury verdicts ranged from $7 million to $495 million per family.
- There is no single claim deadline because this is not a class action. New lawsuits are limited by each state’s statute of limitations.
If you searched “Similac lawsuit,” here is the direct answer: yes, it’s real, and it just hit a major milestone. Abbott Laboratories, the maker of Similac, agreed in late August 2026 to settle roughly 2,000 lawsuits over necrotizing enterocolitis (NEC), a life-threatening intestinal disease, for $670 million.
This affects families whose premature infants were fed Similac cow’s milk-based formula in a neonatal intensive care unit (NICU) and later developed NEC. The most important number right now is $670 million, the size of the newly announced settlement group. The most important date is August 21, 2026, when Abbott confirmed the deal.
This article breaks down what’s confirmed, what’s still pending, and what a new filer needs to know. One detail most coverage buries: this is not a class action, so there’s no shared claim form waiting for you to sign.
The Facts
| Category | Detail |
|---|---|
| Case | MDL No. 3026, In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation (individual lawsuits, not a class action) |
| Status | Settlement agreements covering about 2,000 infant cases announced August 21, 2026; roughly 1,700 lawsuits covering 12,700 infants remain unresolved |
| Fund Size | $670 million (Abbott settlement group, announced August 2026) |
| Est. Per Person | Not yet broken down publicly. Attorney estimates for individual NEC claims range roughly $45,000 to $600,000 or more, depending on severity |
| Claim Deadline | Not applicable to the $670 million group. New cases face state statutes of limitations, generally 2 to 4 years, with possible extensions |
| Administrator | Not yet confirmed. These are attorney-negotiated individual settlements, not a common claims-fund process |
| Proof Needed | NICU feeding records, an NEC diagnosis (Bell stage II or III), and documentation of premature birth |
Is the Similac Lawsuit Real in 2026?
Yes, the Similac lawsuit is real, and it reached a turning point this year. Abbott Laboratories has been fighting thousands of individual lawsuits since 2022 over claims that Similac’s cow’s milk-based formulas raise the risk of NEC in premature infants.
The litigation moved from scattered filings to serious money on the table. In April 2026, a Cook County, Illinois jury awarded $70 million to four families. Four months later, Abbott agreed to settle a much larger group.
None of this happened quietly. Court dockets, jury verdicts, and Abbott’s own settlement announcement all confirm the case is active and consequential.
Key facts confirming this is real:
- Federal court oversight under MDL No. 3026, Northern District of Illinois
- A sitting federal judge, Rebecca R. Pallmeyer, presiding
- Multiple jury verdicts against Abbott since 2024
- A named $670 million settlement group announced in August 2026
Is There a Similac Class Action Lawsuit?
No, there is not a Similac class action lawsuit. NEC cases are filed and resolved individually, even though they’re consolidated for pretrial handling.
That consolidation is called multidistrict litigation, or MDL. All federal Similac and Enfamil NEC cases sit under MDL No. 3026 before Judge Rebecca Pallmeyer in the Northern District of Illinois.
The difference matters for your wallet. In a class action, one settlement fund gets divided among a defined class. In an MDL, each family’s case gets evaluated and, if resolved, paid on its own facts.
That’s why the $670 million figure isn’t a per-person number you can divide by a headcount. It’s the combined value of roughly 2,000 separately negotiated settlements.
Key Takeaway: The Similac lawsuit is a real, active multidistrict litigation, not a class action, so there is no shared settlement pot to file a simple claim against.
Similac Lawsuit Settlement Amounts: What Has Been Paid So Far
Similac lawsuit settlement amounts have moved from single jury verdicts to a large group settlement in 2026. Three figures anchor everything else you’ll read about payouts.
Confirmed dollar figures in this litigation:
| Event | Amount | Date |
|---|---|---|
| Gill case jury verdict (Missouri) | $495 million | July 2024 |
| Cook County jury verdict, 4 families | $70 million | April 2026 |
| Abbott group settlement, ~2,000 infants | $670 million | Announced August 21, 2026 |
The Gill verdict, which awarded $495 million to a mother whose infant suffered permanent brain damage after NEC, was under appeal. It was folded into the $670 million settlement group announced in August.
Abbott has not disclosed how the $670 million will be divided among the roughly 2,000 covered families. Severity of injury, medical costs, and individual case strength all factor into private settlement negotiations.
How Much Is the $670 Million Similac Settlement Paying Per Family?
Not yet determined. Abbott and plaintiffs’ attorneys have not released a per-family breakdown of the $670 million settlement.
Mass tort settlements like this one typically use a confidential allocation matrix instead of one flat number. Attorneys and a court-appointed neutral often grade each case by injury severity, medical expenses, and the strength of the causation evidence.
That means two families in the same settlement group can receive very different amounts. A case involving a child’s death or permanent disability generally settles higher than a case involving a shorter NICU stay with full recovery.
Reality Check: No legitimate settlement in this case pays out through a text message, a social media ad, or an unsolicited call asking for an upfront fee. If you already have an attorney handling a Similac case, your payment will come through that attorney’s office, not a stranger’s link.
Similac NEC Lawsuit Payout Range by Injury Severity
Attorney-published estimates, not confirmed settlement fund data, put individual Similac NEC payouts anywhere from $45,000 to more than $600,000. These figures come from law firms tracking past verdicts and settlements, and they are not guarantees.
Rough severity tiers cited by plaintiffs’ firms:
- Milder NEC cases with full recovery: lower five figures to low six figures
- Cases requiring bowel surgery or long hospitalization: mid six figures
- Cases involving permanent disability or death: potentially seven or eight figures, as seen in the Gill and Cook County verdicts
Jury verdicts sit at the high end because they include punitive damages meant to punish a company, not just compensate a family. Negotiated settlements, including the $670 million group, tend to land lower per case since both sides are avoiding trial risk.
Key Takeaway: Published payout ranges come from attorney estimates and past jury verdicts, not from a confirmed per-person schedule for the $670 million settlement.
Who Qualifies for the Similac NEC Lawsuit?
You may qualify if your premature infant was fed a Similac cow’s milk-based formula in a NICU and was later diagnosed with necrotizing enterocolitis. Eligibility depends on medical records, not just memory of what happened.
Attorneys reviewing these cases generally look for a similar fact pattern. Not every premature baby who had formula and later developed NEC will have a viable claim.
Criteria commonly cited by law firms handling these cases:
- Infant born premature, typically before 37 weeks, with many claims involving babies born before 33 weeks
- Fed a cow’s milk-based product such as Similac Special Care, NeoSure, Human Milk Fortifier, Alimentum, or Sensitive
- Formula given in a NICU setting
- Diagnosed with NEC, generally Bell stage II or III
If your child received donor breast milk exclusively, or a soy-based or amino acid-based formula, the case may not fit this litigation. A free case review from an attorney is the only way to know for sure, and it should always be free.
How to File a Similac Formula Lawsuit
Filing means retaining an attorney who submits your case into the existing MDL structure, not filling out a public claim form. Here’s the general process reported across law firm case pages and court filings.
- Contact a law firm that handles NEC baby formula litigation for a free case evaluation.
- Sign a retainer agreement if the firm agrees to take your case.
- Authorize release of your child’s NICU and medical records.
- Let the firm’s medical experts review causation between the formula and the NEC diagnosis.
- Have your case filed in state court or transferred into MDL No. 3026 in federal court.
- Participate in any required case census or plaintiff profile form, as ordered by the court.
- Wait through discovery, possible bellwether selection, and settlement talks or trial.
There is no cost to start this process. Similac lawsuit attorneys in this litigation work on contingency, meaning they only get paid if your case results in money.
What Documents Do You Need to File a Similac Lawsuit?
You need medical documentation proving your baby was fed Similac and later diagnosed with NEC. Attorneys use these records to build causation, which is the legal link between the formula and the injury.
Documents attorneys typically request:
- NICU feeding logs showing formula brand and type
- Hospital discharge records and pediatric surgical notes
- Pathology reports confirming an NEC diagnosis and Bell stage
- Records of any bowel surgery, ostomy, or long-term complications
- Proof of gestational age and birth weight at delivery
If a hospital didn’t clearly document which formula your baby received, that’s not automatically disqualifying. Attorneys can sometimes reconstruct feeding history through pharmacy and nursing records.
Key Takeaway: Filing a Similac lawsuit means building a medical record trail, not submitting an online form to a settlement fund, since no common claims process for new filers exists yet.
Similac Lawsuit Update: Latest News for 2026
The biggest 2026 development is Abbott’s $670 million settlement announcement on August 21. That came one day after news broke that the underlying $495 million Gill verdict had itself reached a settlement as part of the group.
Confirmed 2026 timeline of major events:
| Date | Development |
|---|---|
| April 9-10, 2026 | Cook County jury awards $70 million to 4 families against Abbott |
| August 20, 2026 | Settlement reported for the $495 million Gill verdict |
| August 21, 2026 | Abbott announces $670 million settlement covering ~2,000 infants |
| September 1, 2026 | Mead Johnson wins first federal NEC bellwether trial (Enfamil) |
Abbott still faces roughly 1,700 lawsuits covering about 12,700 infants that fall outside the new settlement group. That means this litigation is far from over, even with $670 million now committed.
What Happened in the Mead Johnson Enfamil Trial?
A federal jury rejected NEC claims against Mead Johnson, the maker of Enfamil, on September 1, 2026. This was the first baby formula NEC trial held in federal court, making it a closely watched bellwether.
The case involved a mother whose son died after developing NEC as a premature infant. The jury sided with Mead Johnson, finding the formula did not cause the death.
This matters for Similac plaintiffs too, since Abbott and Mead Johnson cases sit in the same MDL and share legal and scientific arguments. A defense win for one manufacturer can shape how both companies approach future settlement talks.
Results across this litigation have been inconsistent. Some juries have awarded hundreds of millions of dollars, while others, along with several judges, have sided with the formula makers.
Similac Lawsuit Deadline: How Much Time Do You Have to File?
There is no single Similac lawsuit deadline because this isn’t a class action with one claims-filing window. Instead, each new case is governed by the statute of limitations in the state where the injury occurred.
Most states give families roughly two to four years from the date of injury, or from when the injury was discovered, to file a personal injury claim. Because NEC often isn’t linked to formula until years later, a legal concept called the discovery rule can extend that window.
Special rules also frequently apply when the injured person is a minor, which can pause or extend the clock in many states. That’s not a guarantee, and it varies significantly by jurisdiction.
Reality Check: Waiting to “see how the $670 million settlement plays out” before contacting an attorney can cost you your legal window. Deadlines run on your state’s law, not on Abbott’s settlement announcements.
What Is Similac and Why Is Abbott Being Sued?
Similac is a baby formula brand made by Abbott Laboratories, widely used in NICUs across the United States for decades. The lawsuits claim Abbott knew cow’s milk-based formulas raised NEC risk in premature infants and didn’t adequately warn parents or hospitals.
Plaintiffs point to research, including a 2024 Cochrane systematic review, showing donor human milk lowers NEC risk compared to formula in high-risk preemies. The claim isn’t that formula is dangerous for all babies, it’s that it’s riskier for extremely premature, low birth weight infants specifically.
Abbott disputes that framing and argues NEC has multiple possible causes. The company has said its product warnings would not have changed clinical feeding decisions at the time.
What Is Necrotizing Enterocolitis (NEC)?
Necrotizing enterocolitis is a serious intestinal disease that mainly affects premature infants, causing tissue in the bowel to become inflamed and die. In severe cases, a hole can form in the intestine, letting bacteria spread through the body.
Doctors grade NEC severity using the Bell staging system, from stage I (mild) to stage III (severe, often requiring surgery). Most lawsuits in this litigation involve stage II or III diagnoses.
Treatment can range from stopping feedings and IV antibiotics to emergency bowel surgery. Long-term effects can include short bowel syndrome, developmental delays, or death in the most severe cases.
Similac NEC Lawsuit vs. the 2022 Similac Recall: What’s the Difference?
The Similac NEC lawsuit and the 2022 Similac powder recall are two separate issues involving the same company. The 2022 recall involved bacterial contamination concerns in specific powder formula lots, unrelated to NEC claims.
The NEC litigation instead argues that cow’s milk-based Similac formula itself, when properly manufactured and used as directed in a NICU, carries an elevated NEC risk for premature infants. This is a design and warning claim, not a contamination claim.
It’s a distinction worth knowing before you search for your own case. A parent affected only by the 2022 recall is dealing with a different legal issue than a parent whose premature baby developed NEC.
Abbott Laboratories’ Response to the Similac Lawsuit
Abbott has consistently defended the safety of its formula products while agreeing to resolve a portion of the litigation through settlement. The company has argued in court filings that NEC has no single proven cause and that its formulas meet all regulatory standards.
At the same time, Abbott chose to settle roughly 2,000 cases for $670 million rather than litigate each one to verdict. That’s a business decision as much as a legal one, weighing trial risk against a negotiated resolution.
Abbott has not issued a public statement admitting its formula causes NEC. Settling a lawsuit is not the same as admitting fault, a distinction that applies to nearly every mass settlement of this kind.
Key Takeaway: Abbott is settling a large slice of the litigation while still contesting the underlying safety claims, and roughly 1,700 lawsuits remain unresolved.
What Happens Next
August 21, 2026: Abbott confirms the $670 million settlement covering about 2,000 infant cases.
September 1, 2026: Mead Johnson wins the first federal NEC bellwether trial, a result likely to influence settlement posture across the MDL.
Expected, ongoing 2026: Additional bellwether trials proceed for the roughly 1,700 remaining Abbott lawsuits and the broader Mead Johnson caseload.
Expected, later 2026 and beyond: Individual settlement negotiations continue case by case for infants not covered in the August agreement; no global class-wide resolution has been announced.
Frequently Asked Questions
Is the Similac lawsuit a scam?
No, the Similac lawsuit is a real, active piece of federal litigation under MDL No. 3026.
It involves real jury verdicts and a confirmed $670 million settlement announced in August 2026.
Be cautious of anyone contacting you demanding upfront payment to “process” a claim.
How much money can I get from the Similac lawsuit?
There is no confirmed flat payout amount, since this is not a class action.
Attorney estimates for individual cases range roughly $45,000 to $600,000 or more, and jury verdicts have gone much higher.
Your amount would depend on injury severity and case-specific facts.
Do I need a lawyer to file a Similac lawsuit?
Yes, filing requires an attorney to build and submit your case, since there is no public claim form.
Most firms handling NEC cases work on contingency, so there’s no upfront cost.
A free case review can confirm whether your situation fits the litigation criteria.
What is MDL No. 3026?
MDL No. 3026 is the federal multidistrict litigation consolidating Similac and Enfamil NEC lawsuits.
It’s based in the Northern District of Illinois before Judge Rebecca R. Pallmeyer.
Consolidation streamlines pretrial proceedings, but each case is still resolved individually.
Is the $670 million Similac settlement final?
The settlement covers roughly 2,000 infant cases and was announced August 21, 2026.
It does not resolve the broader litigation, since about 1,700 lawsuits remain active.
Final payment terms for individual families have not been publicly disclosed.
Can I still file a new Similac NEC lawsuit in 2026?
Possibly, if your state’s statute of limitations hasn’t expired and your case fits the eligibility criteria.
Deadlines generally run two to four years from injury or discovery, with exceptions for minors.
An attorney can confirm your specific filing window based on your state.
What’s the difference between the Similac lawsuit and the Enfamil lawsuit?
Both involve NEC claims against cow’s milk-based formula makers within the same MDL.
Similac lawsuits target Abbott Laboratories, while Enfamil lawsuits target Mead Johnson.
Verdicts and settlements have differed between the two companies, most recently with Mead Johnson winning its first federal trial.
If you believe your premature baby’s NEC diagnosis is connected to Similac formula, the next concrete step is gathering NICU records and speaking with an attorney about your state’s filing deadline. Watch for further case developments given that roughly 1,700 Abbott lawsuits remain unresolved after the August 21, 2026 settlement announcement.
